Europe Medical Cannabis Market Forecast
Base Year: 2023
Historical Years: 2018-2023
Forecast Years: 2024-2032
Market Size in 2023: USD 2,167.8 Million
Market Forecast in 2032: USD 11,093.7 Million
Market Growth Rate: 19.3% (2024-2032)
The Europe medical cannabis market was valued at USD 2,167.8 Million in 2023 and is projected to grow to USD 11,093.7 Million by 2032, with an expected compound annual growth rate (CAGR) of 19.3% from 2024 to 2032.
Europe Medical Cannabis Market Trends:
The market in Europe is primarily driven by the increasing acceptance of cannabis-based treatments by healthcare professionals influenced by extensive research on its therapeutic potential. Moreover, the rapid expansion of clinical trials and studies into cannabis-based medicines is paving the way for more evidence-based endorsements and expanding market reach. Additionally, supportive government policies across Europe are becoming more accommodating, allowing regulated usage for medical purposes, thereby accelerating market growth.
Furthermore, rising chronic conditions such as cancer and neurological disorders are driving higher demand for alternative therapies, with medical cannabis being at the forefront, resulting in significant market expansion. Besides this, the strong of well-established healthcare infrastructures across Europe is supporting the streamlined integration of cannabis-based treatments into existing frameworks, which is providing an impetus to the market. In line with this, public awareness campaigns regarding the benefits of medical cannabis are improving perceptions and enhancing the market outlook.
Request Free Sample Report: https://www.imarcgroup.com/europe-medical-cannabis-market/requestsample
Europe Medical Cannabis Market Scope and Growth Analysis:
The scope of the market in Europe is significantly expanding due to the integration of cannabis-based treatments within mainstream healthcare. Moreover, increasing investments in technological innovations for the cultivation and processing of medical cannabis are enhancing product quality and supply chain efficiency, which is also broadening the market scope. Besides this, the diversification of cannabis-derived products, such as oils, capsules, and topicals catering to a variety of patient preferences, is positively impacting the market. The scope of the market is broadened by the strategic collaborations between pharmaceutical giants and cannabis producers, ensuring consistent quality and wider distribution channels.
As per market analysis, continual innovations in extraction techniques and delivery systems are contributing to better patient outcomes, thus encouraging wider usage and extending market reach. Additionally, the growing awareness initiatives are educating both the public and medical professionals which is facilitating the market. In line with this, several specialized clinics focusing on cannabis treatments are embedding these products into the medical landscape and diversifying the market applications.
We explore the factors propelling the Europe medical cannabis market growth, including technological advancements, consumer behaviors, and regulatory changes.
Europe Medical Cannabis Industry Segmentation:
The market report offers a comprehensive analysis of the segments, highlighting those with the largest Europe medical cannabis market share. It includes forecasts for the period 2024-2032 and historical data from 2018-2023 for the following segments.
Breakup by Species:
- Indica
- Sativa
- Hybrid
Breakup by Derivative:
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)
- Others
Breakup by Application:
- Cancer
- Arthritis
- Migraine
- Epilepsy
- Others
Breakup by End Use:
- Pharmaceutical Industry
- Research and Development Centers
- Others
Breakup by Route of Administration:
- Oral Solutions and Capsules
- Smoking
- Vaporizers
- Topicals
- Others
Breakup by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Competitor Landscape:
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
Ask Analyst For Customization: https://www.imarcgroup.com/request?type=report&id=3059&flag=C
Other key areas covered in the report:
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Market Dynamics
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
- Top Winning Strategies
- Recent Industry News
- Key Technological Trends & Development
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
